During the developing COVID-19 pandemic, the Ludwig Institute for Cancer Research, Oxford Branch is taking measures to prevent the spread of the disease.
Departments are instructed by the University’s Registrar to work from home and manage building closures. This is to restrict any contact between individuals as far as possible.
The University remains open and operating as far as possible with the following restrictions:
- Only essential activities are continuing on site (e.g. research relating to Covid-19 or that of national importance, or the maintenance of critical research resources). Departments are responsible for defining what is essential, in line with divisional guidance, and should provide appropriate operating procedures.
- Other research and teaching continues remotely where possible and students return home (if possible and where that has not already happened)
- Departments physically close except where essential activities have to be done on site. Staff work remotely where possible. Only core support functions and other essential activities continue on site and only with critical staff on site – e.g. building access and maintenance, security, maintenance of research resources.
Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
Spingardi P. and Kriaucionis S., (2020), Nature chemical biology
Chauveau A. et al, (2020), Immunity
Liu D. et al, (2020), Cell death & disease, 11
Macklin PS. et al, (2020), The Journal of pathology, 250, 593 - 611
Thursday, 16 July 2020, 11am to 12pm
Speakers: Prof Jason Mills
Thursday, 24 September 2020, 11am to 12pm
Speakers: Prof Kevin Foster
Thursday, 29 October 2020, 11am to 12pm